Doctors track best drugs to stop eye disease from spreading
NCT ID NCT04182984
Summary
This study observes 200 adults in China with new-onset ocular myasthenia gravis, a condition causing droopy eyelids and double vision. It aims to see which standard immunosuppressant medications work best to control the eye symptoms, prevent the disease from spreading to other muscles, and have the fewest side effects. Researchers will track patients' progress over time to identify which treatments and patient factors lead to the best outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tangdu Hospotal
RECRUITINGXi'an, Shaanxi, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.